Tazemetostat Expanded Access Program for Adults With Solid Tumors
Latest Information Update: 25 Mar 2024
At a glance
- Drugs Tazemetostat (Primary)
- Indications Carcinoma; Chordoma; Ovarian cancer; Sarcoma; Solid tumours; Thoracic neoplasms
- Focus Expanded access; Therapeutic Use
- Sponsors Epizyme
Most Recent Events
- 05 Jul 2023 Status changed from recruiting to completed.
- 16 Aug 2021 Status changed from suspended to recruiting.
- 18 Mar 2019 New trial record